Sign in

CIK 0001601830

  • Large accelerated filer

RECURSION PHARMACEUTICALS, INC.

Sign in to watch
Ticker
RXRX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
464099738
Phone
+1 385-269-0203
Business address
41S RIO GRANDE STREET, SALT LAKE CITY, UT, 84101
Former names
Recursion Pharmaceuticals, LLC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$701,222
in 5 filings, $701K under 10b5-1 plans

Net −$701,222. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-09-12 Secora Michael Chief Financial Officer Exercise or conversion 10b5-1 +37,500 $2.22 $83K 900,686
2023-09-12 Secora Michael Chief Financial Officer Sale 10b5-1 −25,000 $8.43 $211K 875,686
2023-09-12 Secora Michael Chief Financial Officer Exercise or conversion · Stock Option (Right to Buy) 10b5-1 −37,500 1,372,635
2023-09-06 Gibson Christopher Chief Executive Officer Exercise or conversion +31,250 $2.48 $78K 905,056
2023-09-06 Gibson Christopher Chief Executive Officer Sale −33,765 $8.78 $297K 871,291
2023-09-06 Gibson Christopher Chief Executive Officer Conversion +4,000 4,000
2023-09-06 Gibson Christopher Chief Executive Officer Sale −4,000 $8.83 $35K 0
2023-09-06 Gibson Christopher Chief Executive Officer Conversion +20,000 20,000
2023-09-06 Gibson Christopher Chief Executive Officer Sale −20,000 $8.83 $177K 0
2023-09-06 Gibson Christopher Chief Executive Officer Conversion +1,000 1,000
2023-09-06 Gibson Christopher Chief Executive Officer Sale −1,000 $8.84 $9K 0
2023-09-06 Gibson Christopher Chief Executive Officer Exercise or conversion · Stock Option (Right to Buy) −31,250 500,000
2023-09-06 Gibson Christopher Chief Executive Officer Conversion · Class B Common Stock −4,000 523,000
2023-09-06 Gibson Christopher Chief Executive Officer Conversion · Class B Common Stock −20,000 448,000
2023-09-06 Gibson Christopher Chief Executive Officer Conversion · Class B Common Stock −1,000 120,875
2023-09-05 Borgeson Blake Director Sale −8,885 $8.79 $78K 7,451,845
2023-08-24 Larson Tina Marriott President and COO Exercise or conversion 10b5-1 +3,000 $1.06 $3K 421,782
2023-08-24 Larson Tina Marriott President and COO Sale 10b5-1 −2,937 $8.64 $25K 418,845
2023-08-24 Larson Tina Marriott President and COO Sale 10b5-1 −63 $9.45 $596 418,782
2023-08-24 Larson Tina Marriott President and COO Exercise or conversion · Stock Option (Right to Buy) 10b5-1 −3,000 529,000

Page 32 of 41 · 805 trades